APR 08, 2015 02:33 PM PDT

Allergy Drug Inhibits Hepatitis C in Mice: NIH

WRITTEN BY: Will Hector
An over-the-counter drug indicated to treat allergy symptoms limited hepatitis C virus activity in infected mice, according to a National Institutes of Health study. The results suggest that the drug, chlorcyclizine HCl (CCZ), potentially could be used to treat the virus in people. Results were published April 8 in Science Translational Medicine.

The hepatitis C virus (HCV) causes liver inflammation and often leads to serious complications such as cirrhosis. Early diagnosis and treatment of HCV can prevent liver damage. Drugs are available to treat HCV, but costs can reach tens of thousands of dollars.

"Although hepatitis C is curable, there is an unmet need for effective and affordable medication," said lead author T. Jake Liang, M.D., senior investigator at NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). "CCZ is a promising candidate for part of a treatment regimen for this potentially life-threatening disease."

Conducted at the NIH campus in Bethesda, Maryland, the study found that CCZ blocked the early stage of HCV infection likely by impairing the ability of the virus to enter human liver cells grafted in the mice. The outcome was similar to that of commonly used antiviral drugs but without those drugs' toxic side effects.

"Using an innovative high-throughput screening process, we identified CCZ as a potent inhibitor of hepatitis C," said Anton Simeonov, Ph.D., acting scientific director of NIH's National Center for Advancing Translational Sciences (NCATS), which collaborated in the study. "Identifying already approved drugs from the NCATS Pharmaceutical Collection may offer a faster route to potential discovery of treatments for all diseases."

The researchers will next study how the drug affects people. CCZ is currently used for the treatment of allergies, not for HCV. "People should not take CCZ to treat their hepatitis C until it has been demonstrated that CCZ can be used safely and effectively for that purpose," cautions Liang.

"NIH research is vital to finding creative solutions for some of today's most serious public health issues," said NIDDK Director Griffin P. Rodgers, M.D. "The CCZ medication may eventually provide an affordable alternative to costly options, especially in low-resource communities where hepatitis C infection is widespread."

(Source: NIH/National Institute of Diabetes and Digestive and Kidney Diseases)
About the Author
  • Will Hector practices psychotherapy at Heart in Balance Counseling Center in Oakland, California. He has substantial training in Attachment Theory, Hakomi Body-Centered Psychotherapy, Psycho-Physical Therapy, and Formative Psychology. To learn more about his practice, click here: http://www.heartinbalancetherapy.com/will-hector.html
You May Also Like
SEP 17, 2019
Immunology
SEP 17, 2019
T Cell Stimulation for Zika Vaccine Design
Immune cells called CD4+ T cells could be important mediators of protection against the Zika virus...
SEP 17, 2019
Health & Medicine
SEP 17, 2019
European Respiratory Society Task Force Sarcoidosis Patient Survey
Sarcoidosis is a rare, granulomatous disease that is found in the lungs of 90% of people diagnosed, but it can affect any organ in the body. More than 2/3 ...
SEP 17, 2019
Drug Discovery
SEP 17, 2019
PARP Inhibitors Boost Immune Efficacy
In a recent research study, precision cancer drugs called PARP inhibitors are previously known to boost the immune system were found to spark a powerful im...
SEP 17, 2019
Microbiology
SEP 17, 2019
In Space, Dormant Viruses Can Reactivate
Some astronauts have lived onboard the International Space Station for hundreds of days. Researchers are learning more about the things that can happen in that time....
SEP 17, 2019
Immunology
SEP 17, 2019
Fecal Transplant improves ASD
Our understanding of the brain-gut connection is increasing by the day. Individuals with autism spectrum disorder (ASD) also experience gastrointestinal sy...
SEP 17, 2019
Cardiology
SEP 17, 2019
Opioid Addiction Comes With Increased Risk Of Infection
Public health officials have put decades of work into the battle against infectious diseases. Now, this progress is at risk of being dismantled. A recent s...
Loading Comments...